background clinical phenotype varies cystic fibrosis cf patients identical cf transmembrane conductance regulator cftrgenotype suggesting genetic modifiers exist transgenic mice overexpress scnn1beta present lung disease symptoms mutations variants scnn1beta potentially modulate clinical phenotype cf patients methods analysed dhplc scnn1beta scnn1gamma genes NUMBER patients classical cf patients classified groups according cftr genotype severity NUMBER patients severe genotype unexpectedly mild lung phenotype NUMBER patients mild genotype severe lung phenotype results NUMBER patients NUMBER carrying missense mutation novel pthr313met scnn1beta pleu481gln scnn1gamma previously described pgly589ser scnn1beta pval546ileu scnngamma pthr313met identified cf patient mild genotype severe lung phenotype suggesting act increasing enac activity variants identified cf patients severe genotype mild lung phenotype suggesting decrease enac activity function enac nasal epithelia patients evaluated nasal potential difference measurements did support fact variants functional nasal epithelium conclusion results suggest genetic variants enacbeta gamma genes modulate disease severity majority cf patients cf like